Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
Alexandria Beilina(National Institutes of Health), Sean Chong, Kathrin Brockmann(Oregon Health & Science University), Lois E. Greene(National Institutes of Health), David J. Burn(Newcastle Hospitals - Campus for Ageing and Vitality), Honglei Chen(Central South University), Gavin Charlesworth, Ruth Chia(National Institutes of Health), Sigurlaug Sveinbjörnsdóttir(Reykjavík University), Henk W. Berendse, Maciej B. Olszewski(National Institutes of Health), Suneil K. Kalia(University Health Network), David N. Hauser(Max Planck Institute for Medical Research), Kelechi Ndukwe(Cell and Gene Therapy Catapult), Michael von Bonin(Urologische Klinik München), Alessandro Biffi, Laura Civiero(University of Padua), Manu Sharma(Hertie Institute for Clinical Brain Research), Yoav Ben‐Shlomo(University of Bristol), Rob M.A. de Bie(Amsterdam Neuroscience), María Martínez(Inserm), Una‐Marie Sheerin, Elisa Greggio(University of Padua), Mohamad Saad(Université Toulouse III - Paul Sabatier), Mark Cookson(National Institute of Neurological Disorders and Stroke), Vincent Plagnol(University College London), Andrés M. Lozano(University Health Network), Claudia Schulte(School of the Art Institute of Chicago), Suzanne Lesage(Centre National de la Recherche Scientifique), José Brás(School of the Art Institute of Chicago), Lorraine V. Kalia(University Health Network), Alice Kaganovich(National Institutes of Health), Veerle Baekelandt(KU Leuven), Jean‐Marc Taymans(KU Leuven), Javier Simón‐Sánchez(Amsterdam UMC Location Vrije Universiteit Amsterdam), Roger A. Barker(University of Cambridge), Zoltán Bochdanovits, Evy Lobbestael(KU Leuven), Janet Brooks, Kailash P. Bhatia(National Hospital for Neurology and Neurosurgery), Dena G. Hernandez, Hien Chau, Ravindran Kumaran(Cell and Gene Therapy Catapult), Sampath Arepalli(National Institutes of Health), Iakov N. Rudenko(Cell and Gene Therapy Catapult), Mike A. Nalls(Alzheimer's Association), Daniela Berg(Christian-Albrechts-Universität zu Kiel)
Cited by 367
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Deep Brain Stimulation for Treatment-Resistant Depression
|Neuron|2005|4.1k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k